Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JAK inhibitors
Fierce Pharma
New Incyte CEO takes 'fresh look' at business, outlines BD plan
Incyte will look for “derisked pre-revenue or revenue-stage opportunities,” new CEO Bill Meury said.
Angus Liu
Aug 4, 2025 11:16am
Soterios looks to ph. 3 after win for alopecia areata cream
May 30, 2024 8:14am
Incyte's oral Dupixent rival hits in midphase skin disease trial
Mar 11, 2024 7:16am
How Takeda beat the rest of the industry to snag Nimbus' TYK2
Jan 11, 2024 10:30am
Aclaris lays off 46%, resurrects zunsemetinib for cancer
Dec 20, 2023 6:09am
ASH: AZ spinout Dizal explores FDA path, US partner for PTCL med
Dec 11, 2023 4:30am